Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Healthcare Sector Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies16
  • 7D-5.4%
  • 3M6.4%
  • 1Y17.5%
  • YTD42.4%

Over the last 7 days, the Healthcare industry has dropped 5.4%, driven by a pullback from Hapvida Participações e Investimentos of 43%. In the past year, the industry has gained 17%. Looking forward, earnings are forecast to grow by 23% annually.

Sector Valuation and Performance

Has the Brazilian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Nov 2025R$164.6bR$152.1bR$3.3b12.9x49.6x1.1x
Tue, 14 Oct 2025R$145.9bR$149.9bR$2.5b11.7x58.4x1x
Thu, 11 Sep 2025R$149.5bR$149.9bR$2.5b12.2x59.9x1x
Sat, 09 Aug 2025R$140.7bR$151.4bR$2.0b11.9x69.2x0.9x
Mon, 07 Jul 2025R$139.2bR$149.5bR$2.0b11.3x68.3x0.9x
Wed, 04 Jun 2025R$145.5bR$149.5bR$2.0b10.7x71.4x1x
Fri, 02 May 2025R$131.6bR$147.7bR$1.9b10.8x70.9x0.9x
Sun, 30 Mar 2025R$120.3bR$150.7bR$3.6b10.7x33.2x0.8x
Tue, 25 Feb 2025R$123.5bR$146.7bR$4.7b11x26.5x0.8x
Thu, 23 Jan 2025R$114.4bR$146.7bR$4.7b10.7x24.5x0.8x
Sat, 21 Dec 2024R$111.9bR$146.7bR$4.7b11.5x24x0.8x
Mon, 18 Nov 2024R$131.1bR$148.2bR$5.2b13.7x25.2x0.9x
Wed, 16 Oct 2024R$142.9bR$144.9bR$4.4b10.7x32.5x1x
Fri, 13 Sep 2024R$160.0bR$144.9bR$4.4b11.7x36.4x1.1x
Sun, 11 Aug 2024R$149.6bR$143.8bR$4.3b11.7x35.1x1x
Tue, 09 Jul 2024R$142.2bR$142.9bR$4.2b11.6x34x1x
Thu, 06 Jun 2024R$139.8bR$142.9bR$4.2b11.4x33.4x1x
Sat, 04 May 2024R$142.4bR$140.1bR$3.2b12.3x44.1x1x
Mon, 01 Apr 2024R$141.4bR$140.0bR$3.1b13.1x45.1x1x
Wed, 28 Feb 2024R$142.9bR$132.9bR$2.7b16.9x52.7x1.1x
Fri, 26 Jan 2024R$156.0bR$135.0bR$2.9b18.7x54.1x1.2x
Sun, 24 Dec 2023R$168.4bR$135.0bR$2.9b21x58.4x1.2x
Tue, 21 Nov 2023R$158.4bR$135.0bR$2.9b18.6x54.9x1.2x
Thu, 19 Oct 2023R$144.2bR$126.1bR$2.7b17.9x52.5x1.1x
Sat, 16 Sep 2023R$172.2bR$126.1bR$2.7b20.1x62.6x1.4x
Mon, 14 Aug 2023R$187.0bR$125.0bR$2.7b28.2x70.5x1.5x
Wed, 12 Jul 2023R$184.6bR$116.7bR$2.8b16.7x65.5x1.6x
Fri, 09 Jun 2023R$179.3bR$116.7bR$2.8b16.4x63.4x1.5x
Sun, 07 May 2023R$139.7bR$106.6bR$3.3b14.9x42.5x1.3x
Tue, 04 Apr 2023R$127.0bR$106.3bR$3.3b14.1x38.2x1.2x
Thu, 02 Mar 2023R$145.5bR$98.8bR$4.2b14.7x34.4x1.5x
Sat, 28 Jan 2023R$174.2bR$98.3bR$4.2b15.2x41.8x1.8x
Mon, 26 Dec 2022R$167.6bR$98.3bR$4.2b15.6x40.2x1.7x
Wed, 23 Nov 2022R$167.4bR$98.3bR$4.2b15.8x40.2x1.7x
Price to Earnings Ratio

40.2x


Total Market Cap: R$167.4bTotal Earnings: R$4.2bTotal Revenue: R$98.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Healthcare Sector Price to Earnings3Y Average 47.2x202320242025
Current Industry PE
  • Investors are relatively neutral on the Brazilian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 47.2x.
  • The industry is trading close to its 3-year average PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 7.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 16% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare sector?

BR Market2.03%
Healthcare-5.40%
Biotech2.70%
Pharma2.63%
Medical Equipment-2.35%
Healthcare Services-6.53%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 102x.
    • Analysts are expecting annual earnings growth of 22.0%, which is higher than its past year's earnings growth of 7.1% per year.
  • Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 0.85x.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 31% over the next 5 years.
  • This is better than its past earnings growth rate of 5.4% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 6.5% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HYPE3 HyperaR$25.613.1%
+R$481.0m		24.3%PE19.6x
DASA3 Diagnósticos da AméricaR$2.2913.4%
+R$337.4m		6.5%PS0.2x
MATD3 Hospital Mater DeiR$4.8214.8%
+R$204.7m		12.1%PE19.6x
BIOM3 BiommR$7.5013.5%
+R$113.0m		-18.9%PS6.9x
FLRY3 FleuryR$15.901.3%
+R$109.0m		15.5%PE14.4x

Latest News

HAPV3
R$17.79
Hapvida Participações e Investimentos
7D
-42.7%
1Y
-62.6%

Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Share Price Is Still Matching Investor Opinion Despite 43% Slump

Nov 14
Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Share Price Is Still Matching Investor Opinion Despite 43% Slump
VVEO3
R$1.49
CM Hospitalar S/A
7D
8.0%
1Y
-22.8%
OFSA3
R$23.10
Ouro Fino Saúde Animal Participações
7D
-2.5%
1Y
3.1%

Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Business Is Trailing The Market But Its Shares Aren't

Nov 12
Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Business Is Trailing The Market But Its Shares Aren't
MATD3
R$4.82
Hospital Mater Dei
7D
14.8%
1Y
12.1%

Investors Interested In Hospital Mater Dei S.A.'s (BVMF:MATD3) Revenues

Nov 12
Investors Interested In Hospital Mater Dei S.A.'s (BVMF:MATD3) Revenues
RDOR3
R$46.06
Rede D'Or São Luiz
7D
-2.6%
1Y
56.1%

RDOR3: Future Share Estimates Will Balance Risks And Opportunities Ahead

Analysts have raised their price target for Rede D'Or São Luiz from R$44.41 to R$46.91, citing revised estimations in the company's discount rate, revenue growth, and profit margin projections. Valuation Changes Fair Value Estimate: increased from R$44.41 to R$46.91, reflecting a modest rise in the projected value of the shares.
FLRY3
R$15.90
Fleury
7D
1.3%
1Y
15.5%
AALR3
R$5.00
Alliança Saúde e Participações
7D
-6.9%
1Y
-64.8%

Alliança Saúde e Participações S.A. (BVMF:AALR3) Investors Are Less Pessimistic Than Expected

Nov 08
Alliança Saúde e Participações S.A. (BVMF:AALR3) Investors Are Less Pessimistic Than Expected
BIOM3
R$7.50
Biomm
7D
13.5%
1Y
-18.9%

Revenues Working Against Biomm S.A.'s (BVMF:BIOM3) Share Price Following 27% Dive

Nov 07
Revenues Working Against Biomm S.A.'s (BVMF:BIOM3) Share Price Following 27% Dive
DASA3
R$2.29
Diagnósticos da América
7D
13.4%
1Y
6.5%
ODPV3
R$11.83
Odontoprev
7D
-2.3%
1Y
14.6%
HYPE3
R$25.61
Hypera
7D
3.1%
1Y
24.3%

Hypera's (BVMF:HYPE3) Anemic Earnings Might Be Worse Than You Think

Nov 05
Hypera's (BVMF:HYPE3) Anemic Earnings Might Be Worse Than You Think
QUAL3
R$2.29
Qualicorp Consultoria e Corretora de Seguros
7D
-7.3%
1Y
0.9%
PFRM3
R$8.25
Profarma Distribuidora de Produtos Farmacêuticos
7D
2.6%
1Y
17.0%
ONCO3
R$1.74
Oncoclínicas do Brasil Serviços Médicos
7D
-4.4%
1Y
-55.9%

There's Reason For Concern Over Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Massive 29% Price Jump

Oct 08
There's Reason For Concern Over Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Massive 29% Price Jump
BLAU3
R$12.30
Blau Farmacêutica
7D
-1.4%
1Y
-17.6%